Literature DB >> 21160999

Physiopathology of splanchnic vasodilation in portal hypertension.

María Martell1, Mar Coll, Nahia Ezkurdia, Imma Raurell, Joan Genescà.   

Abstract

In liver cirrhosis, the circulatory hemodynamic alterations of portal hypertension significantly contribute to many of the clinical manifestations of the disease. In the physiopathology of this vascular alteration, mesenteric splanchnic vasodilation plays an essential role by initiating the hemodynamic process. Numerous studies performed in cirrhotic patients and animal models have shown that this splanchnic vasodilation is the result of an important increase in local and systemic vasodilators and the presence of a splanchnic vascular hyporesponsiveness to vasoconstrictors. Among the molecules and factors known to be potentially involved in this arterial vasodilation, nitric oxide seems to have a crucial role in the physiopathology of this vascular alteration. However, none of the wide variety of mediators can be described as solely responsible, since this phenomenon is multifactorial in origin. Moreover, angiogenesis and vascular remodeling processes also seem to play a role. Finally, the sympathetic nervous system is thought to be involved in the pathogenesis of the hyperdynamic circulation associated with portal hypertension, although the nature and extent of its role is not completely understood. In this review, we discuss the different mechanisms known to contribute to this complex phenomenon.

Entities:  

Keywords:  Hyperdynamic circulation; Liver cirrhosis; Portal hypertension; Splanchnic vasodilation; Sympathetic nervous system

Year:  2010        PMID: 21160999      PMCID: PMC2999290          DOI: 10.4254/wjh.v2.i6.208

Source DB:  PubMed          Journal:  World J Hepatol


  146 in total

Review 1.  G-protein coupled receptor kinases as modulators of G-protein signalling.

Authors:  M Bünemann; M M Hosey
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

Review 2.  Activation of hepatic stellate cells--a key issue in liver fibrosis.

Authors:  Helen L Reeves; Scott L Friedman
Journal:  Front Biosci       Date:  2002-04-01

3.  Neuronal nitric oxide synthase and systemic vasodilation in rats with cirrhosis.

Authors:  L Xu; E P Carter; M Ohara; P Y Martin; B Rogachev; K Morris; M Cadnapaphornchai; M Knotek; R W Schrier
Journal:  Am J Physiol Renal Physiol       Date:  2000-12

Review 4.  Animal models of portal hypertension.

Authors:  Juan-G Abraldes; Marcos Pasarín; Juan-Carlos García-Pagán
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

5.  Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene.

Authors:  P A Marsden; H H Heng; S W Scherer; R J Stewart; A V Hall; X M Shi; L C Tsui; K T Schappert
Journal:  J Biol Chem       Date:  1993-08-15       Impact factor: 5.157

6.  Increased heme oxygenase activity in splanchnic organs from portal hypertensive rats: role in modulating mesenteric vascular reactivity.

Authors:  M Fernandez; R W Lambrecht; H L Bonkovsky
Journal:  J Hepatol       Date:  2001-06       Impact factor: 25.083

7.  Administration of N omega-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats.

Authors:  F Y Lee; L A Colombato; A Albillos; R J Groszmann
Journal:  Gastroenterology       Date:  1993-11       Impact factor: 22.682

8.  Catecholamines in plasma from artery, cubital vein, and femoral vein in patients with cirrhosis. Significance of sampling site.

Authors:  J H Henriksen; H Ring-Larsen; N J Christensen
Journal:  Scand J Clin Lab Invest       Date:  1986-02       Impact factor: 1.713

9.  Kidney, lower limb and whole-body uptake and release of catecholamines in alcoholic liver disease.

Authors:  J H Henriksen; H Ring-Larsen; N J Christensen
Journal:  Clin Physiol       Date:  1988-06

10.  Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

Authors:  Mercedes Fernandez; Francesco Vizzutti; Juan Carlos Garcia-Pagan; Juan Rodes; Jaime Bosch
Journal:  Gastroenterology       Date:  2004-03       Impact factor: 22.682

View more
  30 in total

Review 1.  Preoperative Transjugular Intrahepatic Portosystemic Shunt Placement for Extrahepatic Abdominal Surgery.

Authors:  Michelle Philip; Bartley Thornburg
Journal:  Semin Intervent Radiol       Date:  2018-08-06       Impact factor: 1.513

2.  Blood loss, predictors of bleeding, transfusion practice and strategies of blood cell salvaging during liver transplantation.

Authors:  Paolo Feltracco; Marialuisa Brezzi; Stefania Barbieri; Helmut Galligioni; Moira Milevoj; Cristiana Carollo; Carlo Ori
Journal:  World J Hepatol       Date:  2013-01-27

3.  Spectrum of small-bowel mucosal abnormalities identified by capsule endoscopy in patients with portal hypertension of varied etiology.

Authors:  T S Chandrasekar; Gokul Bollu Janakan; Viveksandeep Thoguluva Chandrasekar; Raja Yogesh Kalamegam; Sathiamoorthy Suriyanarayanan; Prasad Menta Sanjeevaraya
Journal:  Indian J Gastroenterol       Date:  2017-01-09

Review 4.  New cellular and molecular targets for the treatment of portal hypertension.

Authors:  Jordi Gracia-Sancho; Raquel Maeso-Díaz; Anabel Fernández-Iglesias; María Navarro-Zornoza; Jaime Bosch
Journal:  Hepatol Int       Date:  2015-03-05       Impact factor: 6.047

Review 5.  Hepatosplanchnic circulation in cirrhosis and sepsis.

Authors:  Meghan Prin; Jan Bakker; Gebhard Wagener
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

6.  Gut-brain chemokine changes in portal hypertensive rats.

Authors:  Joaquin Merino; Maria-Angeles Aller; Sandra Rubio; Natalia Arias; Maria-Paz Nava; Maria Loscertales; Jaime Arias; Jorge-Luis Arias
Journal:  Dig Dis Sci       Date:  2011-02-24       Impact factor: 3.199

7.  Synergistic antioxidant and anti-inflammatory action of N-acetylcysteine in portal hypertensive gastropathy in rats.

Authors:  Francielli Licks; Renata Minuzzo Hartmann; Elizângela Schemitt; Josieli Raskopf Colares; Camila Marques; Henrique Fillmann; Norma Possa Marroni
Journal:  Hepatol Forum       Date:  2022-04-26

8.  Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion.

Authors:  Marijan Kolovrat; Slaven Gojkovic; Ivan Krezic; Dominik Malekinusic; Borna Vrdoljak; Katarina Kasnik Kovac; Tamara Kralj; Domagoj Drmic; Ivan Barisic; Katarina Horvat Pavlov; Andreja Petrovic; Antonija Duzel; Mario Knezevic; Ivan Mirkovic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth; Predrag Sikiric
Journal:  World J Hepatol       Date:  2020-05-27

9.  A half century (1961-2011) of applying microsurgery to experimental liver research.

Authors:  Maria-Angeles Aller; Natalia Arias; Isabel Prieto; Salvador Agudo; Carlos Gilsanz; Laureano Lorente; Jorge-Luis Arias; Jaime Arias
Journal:  World J Hepatol       Date:  2012-07-27

10.  Strain of experimental animals and modulation of nitric oxide pathway: their influence on development of renal failure in an experimental model of hepatorenal syndrome.

Authors:  Marek Saracyn; Janusz Patera; Janusz Kocik; Marek Brytan; Robert Zdanowski; Arkadiusz Lubas; Wojciech Kozłowski; Zofia Wańkowicz
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.